Nilotinib

BCR-ABL kinase inhibitor

Catalog No. SIH-463

0 out of 5 based on 0 customer ratings
CAS No. 641571-10-0
Molecular Formula C28H22F3N7O
SKU: SIH-463 Categories: ,

Clear
SIH-463_Nilotinib_Chemical_Structure.png
Product Name Nilotinib
Description

BCR-ABL kinase inhibitor

Purity >99%
CAS No. 641571-10-0
Molecular Formula C28H22F3N7O
Molecular Weight 529.5
Field of Use Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only.

Properties

Storage Temperature -20ºC
Shipping Temperature Shipped Ambient
Product Type Inhibitor
Solubility Soluble in DMSO (50 mg/ml), chloroform, DMF (~3 mg/ml), water(very poorly soluble, maximum solubility in plain water is estimated to be about 10-20 µM; buffers, serum, or other additives may increase or decrease the aqueous solubility), and ethanol(very poorly soluble)
Source Synthetic
Appearance Crystalline powder
SMILES C5=C([N]1C=C(N=C1)C)C=C(NC(=O)C2=CC(=C(C=C2)C)NC3=NC(=CC=N3)C4=CN=CC=C4)C=C5C(F)(F)F
InChI InChI=1S/C28H22F3N7O/c1-17-5-6-19(10-25(17)37-27-33-9-7-24(36-27)20-4-3-8-32-14-20)26(39)35-22-11-21(28(29,30)31)12-23(13-22)38-15-18(2)34-16-38/h3-16H,1-2H3,(H,35,39)(H,33,36,37)
InChIKey HHZIURLSWUIHRB-UHFFFAOYSA-N
Safety Phrases Classification:
Not a hazardous substance or mixture.

Safety Phrases:
S22 - Do not breathe dust.
S24/25 - Avoid contact with skin and eyes.
S36/37/39 - Wear suitable protective clothing, gloves and eye/face protection.
Cite This Product Nilotinib (StressMarq Biosciences Inc., Victoria BC CANADA, Catalog # SIH-463)

Biological Description

Alternative Names 4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]benzamide
Research Areas Apoptosis, Cancer, Cancer Growth Inhibitors, Cell Signaling, Tyrosine Kinase Inhibitors
PubChem ID 644241
Scientific Background Nilotinib is a potent and selective inhibitor of Bcr-Abl tyrosine kinase, with additional activity against JAK2/STAT5 and MDM2 at the post-translational level. In neurodegenerative disease research, Nilotinib has gained attention for its ability to modulate autophagy and promote the clearance of misfolded proteins, such as alpha-synuclein and tau. These properties are particularly relevant in Parkinson’s and Alzheimer’s disease models, where impaired protein degradation contributes to neuronal dysfunction. Nilotinib’s neuroprotective effects are also linked to its capacity to influence dopaminergic signaling and reduce neuroinflammation, making it a promising candidate for repurposing in neurodegenerative therapeutics.
References 1. Gallipoli P., et al. (2014) Blood.
2. Zhang H., Gu L., Liu T., Chiang K.Y., & Zhou M. (2014) PloS One. 9(6): e100960.

Product Images

<p>Chemical structure of Nilotinib (SIH-463), a BCR-ABL kinase inhibitor. CAS #: 641571-10-0. Molecular Formula: C28H22F3N7O. Molecular Weight: 529.5 g/mol.</p>

Chemical structure of Nilotinib (SIH-463), a BCR-ABL kinase inhibitor. CAS #: 641571-10-0. Molecular Formula: C28H22F3N7O. Molecular Weight: 529.5 g/mol.

Reviews

Reviews

There are no reviews yet.

Be the first to review “Nilotinib”

Your email address will not be published. Required fields are marked *